4H-Thieno[3,4-e]- and 4H-Pyrazolo[4,3-e]-1,2,4-Thiadiazine 1,1-Dioxides. Synthesis, Chemical Properties and Evaluation of their Potential Cardiovascular Activity

Journal of Heterocyclic Chemistry

Volumn 41, Issue 1, 2004, Pages 45-50

  Vega, Salvador ^a   Arranz, María Esther ^a,b  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b Myriad Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYL 4H THIENO[3,4 E] 1,2,4 THIADIAZINE 1,1 DIOXIDE; 3 METHYL 5 NITRO 4H THIENO[3,4 E] 1,2,4 THIADIAZINE 1,1 DIOXIDE; 3,6 DIMETHYL 4H PYRAZOLO[4,3 E] 1,2,4 THIADIAZINE 1,1 DIOXIDE; 5 ACETYL 3 METHYL 4H THIENO[3,4 E] 1,2,4 THIADIAZINE 1,1 DIOXIDE; 5 BROMO 3 METHYL 4H THIENO[3,4 E] 1,2,4 THIADIZINE 1,1 DIOXIDE; 5 CHLORO 3 METHYL 4H THIENO[3,4 E] 1,2,4 THIADIAZINE 1,1 DIOXIDE; CARDIOVASCULAR AGENT; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG SYNTHESIS; NONHUMAN; RAT; REACTION ANALYSIS; VASODILATATION;

EID: 1542316227     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570410107     Document Type: Article

References (23)

1. S. Vega, J. A. Díaz, V. Darias, and C. C. Sánchez Mateo, J. Heterocyclic Chem., 37, 389-393 (2000).
2. M. E. Arranz, J. A. Díaz, S. Vega, M. Campos-Toimil, F. Orallo, I. Cardelús, J. Llenas and A. G. Fernández, Eur. J. Med. Chem., 35, 751 (2000).
3. M. E. Arranz, J. A. Díaz, S. T. Ingate, M. Witvrouw, C. Pannecouque, J. Balzarini, E. De Clerq and S. Vega, J. Med. Chem., 41, 4109 (1999).
4. M. E. Arranz, J. A. Díaz, S. T. Ingate, M. Witvrouw, C. Pannecouque, J. Balzarini, E. De Clerq and S. Vega, Bioorg. Med. Chem., 7, 2811 (1999).
5. S. Vega, J. A. Díaz, V. Darias, C. C. Sánchez Mateo and L. M. Albertos, Pharmazie, 53, 130 (1998).
6. M. E. Arranz, J. A. Díaz, E. Morante, C. Pérez, and S. Vega, J. Heterocyclic Chem., 33, 151 (1996).
7. J. A. Díaz, S. Vega, M. A. Expósito, C. C. Sánchez Mateo and V. Darias, Arch. Pharm. Pharm. Med. Chem., 329, 352 (1996).
8. J. A. Díaz, E. Montero, S. Vega, V. Darias, M. L. Tello and S. S. Abdalah, Arch. Pharm. 327, 157 (1994).
9. J. A. Díaz, and S. Vega, J. Heterocyclic Chem., 31, 93 (1994).
10. S. Vega, R. Madroñero, J. A. Díaz, F. Junquera, J. Alonso, V. Darias, L. Bravo and S. Abdalah, Eur. J. Med. Chem., 23 329 (1988).
11. J. R. Empfield, and K. Russell, Annu. Rep. Med. Chem., 30, 81 (1995).
12. M. J. Coghlan, and W. A. Carroll, J. Med. Chem., 44, 1627 (2001).
13. G. A. Patani, and E. J. LaVoie, Chem. Rev., 96, 3147 (1996).
14. J. G. Cannon, in Burger's Medicinal Chemistry and Drug Discovery, Vol. 1, M. E. Wolf, ed, John Wiley & Sons, New York, NY, 1995, pp 783.
15. A. Burger, Prog. Drug Res., 37, 287 (1991).
16. R. E. Busby, in Advances in Heterocyclic Chemistry, Vol. 50, A. R. Katritzky, ed, Academic Press, San Diego, CA, 1990, p 255.
17. J. H. Freeman and E. C. Wagner, J. Org Chem., 16, 815 (1951).
18. E. C. Wagner, J. Org Chem., 5, 133 (1940).
19. R. K. Norris, in The Chemistry of Heterocyclic Compounds, Vol. 44, S. Gronowitz, ed, John Wiley & Sons, New York, NY, 1986, p 631.
20. M. E. Arranz, S. Vega and J. A. Díaz, Heterocycles, 45, 1767 (1997).
21. Y. Girard, J. G. Atkinson, D. R. Haubrich, M. Williams and G. Yarbrough, J. Med. Chem., 25, 113 (1982).
22. R. E. Smith, G. F. Morris and C. R. Hauser, J. Org. Chem., 33, 2562 (1968).
23. M. Jetley and A. H. Weston, Br. J. Pharmacol., 68, 311 (1980).